Back to Search
MICHAEL COONEY, M.D.
M.D.
Internal Medicine Physician
NPI: 1447220876Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
35-032524(OH)
Research & Publications (20)
Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery.
PMID 17139319·Nat Clin Pract Oncol·2006
6-review
Novel vascular targeting/disrupting agents: combretastatin A4 phosphate and related compounds.
PMID 15717941·Curr Oncol Rep·2005
6-review
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.
PMID 15538570·Cancer Chemother Pharmacol·2005
3-trial
A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?
PMID 14733832·Curr Urol Rep·2004
6-review
Novel agents for the treatment of advanced kidney cancer.
PMID 16163253·Clin Adv Hematol Oncol·2004
6-review
Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.
PMID 14734457·Clin Cancer Res·2004
3-trial
Presumed choroidal--retinal arteriole anastamosis after penetrating ocular trauma.
PMID 11039437·Retina·2000
5-case
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.
PMID 19375079·Atherosclerosis·2009
4-observational
How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.
PMID 19609139·Eur J Cardiovasc Prev Rehabil·2009
4-observational
Homocysteine increases the risk associated with hyperlipidaemia.
PMID 19276985·Eur J Cardiovasc Prev Rehabil·2009
4-observational
EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.
PMID 19552291·Ir Med J·2009
4-observational
Increased prevalence of autoimmunity in patients with white spot syndromes and their family members.
PMID 19597107·Arch Ophthalmol·2009
4-observational
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature.
PMID 19056107·Urology·2009
5-case
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
PMID 19265494·Thyroid·2009
3-trial
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
PMID 18414865·Cancer Chemother Pharmacol·2009
3-trial
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
PMID 19433858·Blood·2009
8-other
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
PMID 19451436·J Clin Oncol·2009
3-trial
HeartScore predicts surrogate markers of cardiovascular disease in individuals aged below 40 years.
PMID 19641423·Eur J Cardiovasc Prev Rehabil·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 719 W TOWN ST
COLUMBUS, OH 43222 - Phone
- (614) 228-3036
Quick Facts
- NPI
- 1447220876
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile